Home

Decheng Capital Global Life Sciences Fund IV, 10% Owner: Aardvark Therapeutics AARD Buy · Filed 25/02/19

Trade details

Type
Insider buy
Amount
$10,000,000
Shares · price
625,000 sh · $16.00 a share
Held after
958,412 sh
Trade date
25/02/14
Filed
25/02/19
Days to filing
5 days

First buy since 2023

Insiders buying this week
9 insiders
Holding change
+187.5%

Aardvark Therapeutics trades, last 26 weeks

What else happened in Aardvark Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/15~25/03/16

Decheng Capital Global Life Sciences Fund IV's recent trades